Skip to main content
TipRanks
Go Ultimate75% OFF

AstraZeneca Pharma India Limited (ASTRAZEN) Ratios

44 Followers

AstraZeneca Pharma India Limited Ratios

IN:ASTRAZEN's free cash flow for Q2 2027 was ₹0.00. For the 2027 fiscal year, IN:ASTRAZEN's free cash flow was increased by ₹0.00 and operating cash flow was ₹0.00. See a summary of the company’s cash flow.

Financial ratios
RatiosMar 26Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio1.771.912.612.182.12
Quick Ratio0.731.131.971.681.70
Cash Ratio0.460.761.421.301.35
Solvency Ratio0.190.210.480.290.23
Operating Cash Flow Ratio0.010.090.080.150.30
Short-Term Operating Cash Flow Coverage0.490.0015.4016.5627.92
Net Current Asset Value₹ 6.24B₹ 5.95B₹ 5.67B₹ 4.39B₹ 3.60B
Leverage Ratios
Debt-to-Assets Ratio0.060.020.000.010.01
Debt-to-Equity Ratio0.130.050.010.010.02
Debt-to-Capital Ratio0.110.040.010.010.02
Long-Term Debt-to-Capital Ratio0.000.000.000.000.00
Financial Leverage Ratio2.281.971.511.671.67
Debt Service Coverage Ratio11.99107.6659.0228.0017.43
Interest Coverage Ratio51.99147.13142.86236.3373.32
Debt to Market Cap0.000.000.000.000.00
Interest Debt Per Share46.0614.882.323.143.83
Net Debt to EBITDA-1.18-2.53-2.13-3.27-4.36
Profitability Margins
Gross Profit Margin26.46%41.60%48.03%57.60%55.63%
EBIT Margin11.28%9.21%17.04%13.43%10.43%
EBITDA Margin12.54%11.55%18.19%15.05%12.53%
Operating Profit Margin10.26%12.54%13.23%14.84%8.65%
Pretax Profit Margin11.08%9.13%16.95%13.37%10.31%
Net Profit Margin8.24%6.76%12.47%9.90%7.65%
Continuous Operations Profit Margin8.24%6.76%12.47%9.90%7.65%
Net Income Per EBT74.35%74.02%73.57%74.04%74.18%
EBT Per EBIT108.03%72.79%128.06%90.07%119.22%
Return on Assets (ROA)9.43%7.62%14.98%10.08%7.19%
Return on Equity (ROE)21.49%15.02%22.69%16.87%12.05%
Return on Capital Employed (ROCE)23.18%26.35%23.78%24.78%13.29%
Return on Invested Capital (ROIC)17.00%19.36%17.41%18.13%9.73%
Return on Tangible Assets9.43%7.63%15.01%10.08%7.19%
Earnings Yield0.97%0.55%1.24%1.22%0.97%
Efficiency Ratios
Receivables Turnover10.659.257.658.489.38
Payables Turnover2.142.193.431.871.88
Inventory Turnover1.631.822.952.242.55
Fixed Asset Turnover19.3726.9519.9814.2910.50
Asset Turnover1.141.131.201.020.94
Working Capital Turnover Ratio3.262.822.522.432.34
Cash Conversion Cycle87.6373.0864.7110.72-12.36
Days of Sales Outstanding34.2739.4547.7043.0638.91
Days of Inventory Outstanding224.07200.09123.54163.26143.18
Days of Payables Outstanding170.71166.45106.54195.59194.46
Operating Cycle258.34239.54171.24206.31182.09
Cash Flow Ratios
Operating Cash Flow Per Share2.7326.1511.1523.3240.32
Free Cash Flow Per Share1.2825.456.8419.9136.47
Dividend Paid and CapEx Coverage Ratio0.081.060.552.046.89
Capital Expenditure Coverage Ratio1.8937.352.596.8410.48
Operating Cash Flow Coverage Ratio0.061.836.078.0811.68
Operating Cash Flow to Sales Ratio0.000.040.020.060.13
Free Cash Flow Yield0.02%0.30%0.13%0.61%1.43%
Valuation Ratios
Price-to-Earnings (P/E) Ratio103.53183.4380.5081.90103.57
Price-to-Sales (P/S) Ratio8.5312.3910.048.117.92
Price-to-Book (P/B) Ratio22.2427.5618.2613.8112.48
Price-to-Free Cash Flow (P/FCF) Ratio6047.66333.75759.88163.3969.97
Price-to-Operating Cash Flow Ratio2846.48324.82466.51139.5163.29
Price-to-Earnings Growth (PEG) Ratio1.67-6.481.291.34-3.05
Enterprise Value Multiple66.87104.8053.0450.5958.85
Enterprise Value190.75B207.30B125.01B76.39B59.40B
EV to EBITDA66.87104.8053.0450.5958.85
EV to Sales8.3812.109.657.627.37
EV to Free Cash Flow5942.37325.88730.60153.4865.14
EV to Operating Cash Flow2796.92317.16448.53131.0558.93
Tangible Book Value Per Share349.13307.90283.92235.47204.56
Shareholders’ Equity Per Share349.13308.16284.77235.48204.56
Tax and Other Ratios
Effective Tax Rate0.260.260.260.260.26
Revenue Per Share910.27685.37518.21401.19322.24
Net Income Per Share75.0146.3064.6039.7224.64
Tax Burden0.740.740.740.740.74
Interest Burden0.980.990.991.000.99
Research & Development to Revenue0.000.000.060.000.00
SG&A to Revenue0.160.150.030.030.03
Stock-Based Compensation to Revenue0.000.000.000.000.00
Income Quality0.040.420.170.431.21

Currency in INR